GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dermapharm Holding DMP.DE · EUR

Health Care · XETRA · 🇩🇪 Germany

Compare

38.35

+0.92%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Revenue

€1.16bn

FY2016FY2025

Net income

€132.4m

FY2016FY2025

Free cash flow

€139.4m

FY2016FY2025

Shareholders' equity

€694.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue€1.16bn€1.18bn€1.14bn€1.02bn€942.9m€793.8m€700.9m€572.4m€467.1m€444.5m
Research and development€11.2m€11.5m€10.6m€13.2m€14.2m€12.7m€11.2m€7.0m€6.6m€4.8m
Operating income€221.7m€216.9m€182.9m€243.7m€298.5m€136.9m€119.5m€107.5m€92.1m€86.8m
Net income€132.4m€113.8m€62.4m€134.2m€209.6m€85.8m€77.2m€75.3m€77.7m€16.8m
Diluted earnings per share2.462.111.162.493.871.581.421.381.430.31

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets€2.20bn€2.08bn€2.16bn€1.41bn€1.41bn€1.22bn€1.04bn€704.6m€415.3m€311.7m
Cash and short-term investments€203.4m€121.7m€159.5m€161.4m€172.1m€121.7m€116.0m€213.9m€6.7m€3.8m
Total liabilities€1.50bn€1.47bn€1.62bn€880.3m€907.1m€899.8m€760.4m€448.5m€341.6m€250.9m
Debt€1.05bn€1.07bn€1.08bn€516.4m€580.3m€606.8m€554.6m€304.3m€254.7m€150.6m
Shareholders' equity€694.4m€604.4m€539.2m€531.6m€497.3m€322.0m€278.6m€252.4m€73.7m€56.9m
Shares outstanding54m54m54m54m54m54m54m54m54m54m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations€181.5m€201.4m€219.4m€288.5m€250.4m€131.1m€100.6m€159.1m€86.7m€76.8m
Capital spending−€42.1m−€38.2m−€41.5m−€39.0m−€61.2m−€40.8m−€46.4m−€26.0m−€74.7m−€17.8m
Free cash flow€139.4m€163.1m€177.9m€249.5m€189.2m€90.3m€54.2m€133.2m€12.0m€59.0m
Dividends paid−€48.5m−€47.4m−€56.5m−€116.8m−€47.4m−€43.1m−€41.5m−€41.5m−€41.5m−€41.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue€285.2m€305.8m€295.5m€294.9m€272.1m€302.4m€290.7m€311.6m
Operating income€71.0m€70.7m€53.7m€64.9m€44.5m€59.8m€47.9m€66.1m
Net income€23.2m€45.2m€36.9m€41.2m€20.9m€33.4m€20.5m€32.4m
Diluted earnings per share0.470.910.690.770.390.620.380.60
Cash from operations€43.0m€39.0m€92.0m€44.0m€65.0m€4.0m€71.0m€73.0m
Capital spending−€14.0m−€11.0m−€11.0m−€9.0m−€10.0m−€10.0m−€11.0m−€7.0m
Free cash flow€29.0m€28.0m€81.0m€35.0m€55.0m−€6.0m€60.0m€66.0m
Total assets€2.24bn€2.27bn€2.20bn€2.12bn€2.14bn€2.11bn€2.08bn€2.12bn
Cash and short-term investments€195.6m€254.0m€203.4m€146.6m€165.9m€118.0m€121.7m€124.4m
Debt€139.2m€123.2m€1.05bn€1.01bn€1.01bn€995.3m€979.6m€1.03bn
Shareholders' equity€536.7m€738.9m€694.4m€649.2m€608.2m€638.6m€604.4m€583.7m

Financial ratios

Data as of 29 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin19.0%19.5%14.2%22.3%32.0%17.0%
Net margin11.4%9.6%5.5%13.1%22.2%10.8%
Return on equity19.1%18.8%11.6%25.3%42.1%26.7%
Return on assets6.0%5.5%2.9%9.5%14.9%7.0%
Free cash flow yield10.9%11.7%12.7%15.9%15.1%8.3%
Revenue growth-1.3%4.0%10.8%8.7%18.8%13.3%
Earnings growth16.4%82.4%-53.5%-36.0%144.2%11.2%
Current ratio2.05x1.82x1.60x2.45x3.34x3.01x
Debt to equity1.49x1.60x1.98x0.95x1.15x1.85x
Equity ratio31.5%29.1%25.0%37.6%35.3%26.3%
Interest coverage4.21x3.94x2.70x16.49x30.64x12.69x
R&D as a share of sales1.0%1.0%0.9%1.3%1.5%1.6%
Buybacks as a share of market value0.0%0.0%0.0%0.6%0.5%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.4%8.0%11.7%
Operating income-3.1%10.1%13.8%
Net income-0.5%9.1%26.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin18.7%19.2%20.8%20.1%
Net margin10.5%9.8%11.8%11.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings15.918.436.515.123.136.128.016.4
Price to sales1.81.82.02.05.13.93.12.2

Dividends and splits

Per share, in the currency the company pays

Paid for 7 years. Last went ex-dividend on 29 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.880.900.881.052.170.880.800.77

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.